Floatz logo

Metyrapone

Craniocerebral Trauma

National Center for Research Resources (NCRR)Small moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

93 Active assets in the Craniocerebral Trauma cohort.

Asset / SponsorPhaseRating
MELATONIN
Children's National Research Institute
Phase 4BBB
Valproic Acid
Northwestern University
Phase 4BBB
PROPRANOLOL
Tanta University
Phase 4BBB
N-Acetyl-L-Cysteine
HonorHealth Research Institute
Phase 2BB
NEPENTHE
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB

View all 50 →

Same molecule, other indications

Metyrapone is also rated in:

Insulin ResistanceDormant
B
Indicative ·
62 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
B
Indicative ·
59 / 100
View asset →
obesity disorderDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →